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1977; Zinkernagel et al., 1978; Kisielow et al., 1988b;Katsuiku Hirokawa,² Motoya Katsuki,³§
Sha et al., 1988a; Teh et al., 1988; Berg et al., 1989).and Takehiko Sasazuki*
The role of self-peptides in positive selection has been*Department of Genetics
suggested by the results of research in which aminoMedical Institute of Bioregulation
acid substitutions in residues of the MHC moleculesKyushu University
positioned toward the peptide-binding groove affectedFukuoka 812-82
positive selection (Berg et al., 1990; Jacobs et al., 1990;Japan
Nikolic-Zugic and Bevan, 1990). This involvement has²Department of Pathology and Immunology
been shown more directly using fetal thymic organ cultureTokyo Medical and Dental University
derived from b2-microglobulin-deficient mice and TAP1-Tokyo 113
deficient mice (Ashton-Rickardt et al., 1993; Hogquist etJapan
al., 1993). On the other hand, negative selection is the³Laboratory of Embryonic and Genetic
process that eliminates immature thymocytes bearingEngineering
TCRs specific for self-peptides bound to self-MHC mol-Kyushu University
ecules. It is considered to play a major role in establish-Fukuoka 812-82
ment of self-tolerance (Kappler et al., 1987; Kisielow etJapan
al., 1988a; MacDonald et al., 1988; Sha et al., 1988b;
Murphy et al., 1990). Thus, self-peptides bound to self-
MHC molecules mediate both positive and negative se-Summary
lection through recognition by TCRs expressed on im-
mature thymocytes.The central event in thymic selection of T cells bearing
One explanation for the conceptual paradox between
ab TCRs is their interaction with self-peptides bound
positive and negative selection has led to a differentialto self-MHC molecules. With the use of transgenic
avidity model in which the fate of T cells is determinedmouse lines expressing a single peptide/MHC class II
by the cell surface density of MHC/peptide complexescomplex, we show that CD41 T cells with the preferen-
as well as the intrinsic affinity of TCRs for the ligandstial usage of particular TCR Vas and Vbs were selected
(Janeway et al., 1992). Supporting this model, in vitro
to mature on this complex in lines with the lower ex-
experiments using fetal thymic organ culture have
pression, whereas such CD41 T cells were eliminated
clearly shown that the cell surface density of a singlein the thymus in a line with the relatively high expres-
MHC class I/peptide complex affects the fate of CD81sion. When a low expressing line was crossed with a
T cells expressing the transgenic TCR (Ashton-Rickardt
high expressing line, the frequency of CD41 T cells
et al., 1994; Hogquist et al., 1994; Sebzda et al., 1994).
selected by this complex markedly decreased. Thus,
However, in vitro experiments also suggested that quali-
these results suggest that a single peptide/MHC class
tative difference in the recognition of MHC/peptide com-
II complex, being affected by its cell surface density in plex by TCRs, probably due to the difference in kinetics
the thymus,can serve asboth positively and negatively or comformational change in the interaction, affects the
selecting ligand in vivo. fate of T cells (Hogquist et al., 1994; Spain et al., 1994;
Yoon et al., 1994; Lyons et al., 1996; Sebzda et al., 1996).
Introduction In addition, many studies have revealed that different
thymic stroma cell types expressing MHC molecules
While thediversity of ab T cell receptors (TCRs) theoreti- are involved in these two selection processes: cortical
cally reaches 1015 by random rearrangement of five gene epithelial cells mediate positive selection (Benoist and
segments (Va, Ja, Vb, Db, and Jb) and random nucleo- Mathis, 1989; Berg et al., 1989; Bill and Palmer, 1989),
tide addition (Davis and Bjorkman, 1988), mature T cells whereas bone marrow±derived cells and medullary epi-
express highlyselected TCRs in that theyexhibit tolerance thelial cells mediate negative selection (Marrack et al.,
to self-antigenic peptides and restriction of self±major his- 1988; Burkly et al., 1993; Laufer et al., 1996). Therefore,
tocompatibility complex (MHC) molecules. This mainly re- the effect of TCR ligand density on thymic selection
sults from two reciprocal selection processes, positive remains unclear under physiological T cell differentia-
and negative selection, acting during T cell development tion, in which T cells express a diverse set of TCRs with
in the thymus. Positive selection is the process that various specificities and various affinities or kinetics for
induces the differentiation of CD41CD81 immature thy- a given ligand expressed on different cell types. In par-
mocytes into CD42CD81 or CD41CD82 mature thymo- ticular, very little is known about thymic selection of
cytes that mount immune response on foreign antigenic CD41 T cells, because of the lack of the appropriate
experimental system to follow the fate of CD41 T cells
directed by a given ligand.§Present Address: Department of DNA Biology and Embryo Engi-
The expression of a single MHC class II/peptide com-neering, The Institute of Medical Science, The University of Tokyo,
Tokyo 108, Japan. plex in vivo would overcome the problems described
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above and allow us to analyze the effect of TCR ligand
density on thymic selection of CD41 T cells under nearly
physiological conditions. For this purpose, we took ad-
vantage of the strategy to expressMHC molecules cova-
lently bound to a single peptide described by Kozono
et al. (1994) and developed transgenic mouse lines ex-
pressing a single MHC class II/peptide complex at differ-
ent levels in the thymus. By comparing the fate of CD41
T cells in these lines, we demonstrate here that a single
MHC class II/peptide complex directs both positive and
negative selection of CD41 T cells and that the expres-
sion level of this complex in the thymus plays a crucial
role in determining the fate of CD41 T cells in vivo.
Results
Expression of I-Ab Molecules Covalently Bound
to Ea52-68 in Lymphoid Tissues
of Transgenic Mouse Lines
The peptide derived from MHC class II Ea chain (Ea 52-
68) binds to MHC class II I-Ab molecules (Rudensky et
al., 1991). To express I-Ab molecules bound to Ea52-68
as a single MHC class II/peptide complex in vivo, the
gene to encode I-Abb chain covalently bound to Ea52-
68 was created and injected into fertilized eggs from
I-Abb gene knockout mice (Ao/o) carrying H-2b haplotype
(Cosgrove et al., 1991). Three founder mice, B2H Ao/o,
H3 Ao/o, and B2L Ao/o, were identified. The number of
transgenes integrated in B2H Ao/o was about 20 times
higher than those in H3 Ao/o and B2L Ao/o (data not
shown). Since mice carrying H-2b haplotype lack the Ea
chain expression (Mathis et al., 1983), the endogenous Figure 1. Flow Cytometric Analysis for Expression of I-Ab Molecules
Covalently Bound to Ea52-68 in Transgenic Mouse LinesI-Aab chain associated with I-Abb covalently bound to
Ea52-68 is the only MHC class II molecule expressed (A) Spleen cells from transgenic mouse lines, Ao/oIio/o, and B6 were
stained with the MAb specific for B220 and YAe (right) or Y3P within these mice. However, staining experiments suggested
(middle) or without (left) the pretreatment of YAe. The X and Y axesthat part of Ea52-68 bound to I-Ab moleculeswas replaced
indicate the log fluorescence intensity for B220 and I-Ab or I-Ab/by other peptides (data not shown). As recently described
Ea52-68 complex, respectively.
by Ignatowicz et al. (1996), to avoid this replacement, these (B) Short-term cultured thymic epithelial cells were stained with
transgenic mice were backcrossed with mice carrying Y3P in the presence (open area) or absence (closed area) of YAe
H-2b haplotype and deficient for the invariant chain (Ii) pretreatment after the incubation of the cells with IFN-g. The profile
stained with irrelevent antibody was overlapped with that stained(Viville et al., 1993) that associates with MHC class II
with Y3P in the presence of YAe pretreatment.molecules and leads them to the endocytic compart-
ment where peptide loading takes place (Neefjes and
Ploegh, 1992). Finally, three lines of transgenic mice
in a B cell population of B2H Ao/oIio/o was 24.2 timeslacking the expression of bothwild-type I-Abb and invari-
higher than that of C57BL/6 (B6 [H-2b]), which lacks theant chains, B2H Ao/oIio/o, H3 Ao/oIio/o, and B2L Ao/oIio/o, were
expression of I-Ab/Ea52-68 complex, whereas that ofestablished, and mice hemizygous for the transgenes
H3 Ao/oIio/o and B2L Ao/oIio/o showed only 3.6 and 1.8 timeswere used for further analysis, except for the case espe-
higher levels, respectively.cially noted.
To further characterize the expression of I-Ab/Ea52-68We first examined the expression of I-Ab/Ea52-68
complex in the thymus, immunohistochemical analysiscomplex in these transgenic mice using two monoclonal
was done using YAe. The I-Ab/Ea52-68 complexes wereantibodies (MAbs), Y3P, which is specific for I-Ab irre-
found to be expressed in thymic cortex and medulla inspective of binding peptides (Janeway et al., 1984), and
both B2L Ao/oIio/o and B2H Ao/oIio/o (Figures 2A and 2C).YAe, which is specific for I-Ab bound to Ea52-68 (Murphy
The expression of I-Ab/Ea52-68 complex, however, waset al., 1989; Rudensky et al., 1991). Staining of spleen
scarcely detected in thymic cortex in H3 Ao/oIio/o, althoughcells (Figure 1A) and interferon (IFN)-g-treated thymic
weak positive staining was observed in thymic medullaepithelial cells (Figure 1B) with Y3P was inhibited to the
in this line (Figure 2B). Since the staining was donelevel of the background by preincubation of the cells
simultaneously under the same conditions, it was con-with YAe. These findings indicate that I-Ab molecules
cluded that the expression level of I-Ab/Ea52-68 com-are almost completely occupied with Ea52-68 and are
plex in the thymus from B2H Ao/oIio/o was considerablyexpressed on spleen cells and IFN-g-treated thymic epi-
thelial cells from these mice. The mean intensity for YAe higher than that from H3 Ao/oIio/o and B2L Ao/oIio/o.
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Figure 3. Antigen-Presenting Capacity of Spleen Cells from Trans-
genic Mouse Lines
(A) A T cell hybridoma, BV2-3-1, was cultured with spleen cells
from B6, B2H Ao/oIio/o, and B2H Ao/oIi1/1 in the presence of various
concentrations of 50V. The X and Y axes indicate the concentration
of 50V added to the culture and [3H] thymidine incorporation by the
IL-2-dependent cell line, CTLL, in the presence of 50V, subtracting
that in the absence of 50V, respectively.
(B) A T cell hybridoma, BEa16-3, was cultured with spleen cells from
B6 and transgenic mouse lines in the absence of exogenous Ea52-
68 or B6 spleen cells in the presence of Ea52-68 at 10 mg/ml, and
IL-2 production was quantified by [3H] thymidine incorporation byFigure 2. Immunohistochemical Analysis for I-Ab/Ea52-68 Complex
CTLL. The data indicate the mean plus one standard deviation ofExpression in the Thymus
triplicate cultures.
Thymus sections from B2H Ao/oIio/o (A), H3 Ao/oIio/o (B), and B2L Ao/oIio/o
(C) were simultaneously stained with YAe under the same condi-
tions. For each line, two mice were analyzed independently. Open
covalently bound to Ea52-68 are expressed in trans-arrows indicate cortico-medullary junction.
genic mice of Ao/oIio/o background as a single species in
appropriate form to be recognized by a given TCR.
Antigen Presentation of Spleen Cells
from Transgenic Mouse Lines CD41 T Cell Differentiation Directed by
I-Ab/Ea52-68 Complex in TransgenicTo examine antigen-presenting capacity of spleen cells
from transgenic mouse lines, a T cell hybridoma, BV2- Mouse Lines
Having established transgenic mouse lines expressing3-1, specific for pigeon cytochrome c±derived analog
peptide (50V) restricted by I-Ab molecules (Ogasawara a single MHC class II/peptide complex at different levels
in the thymus, we compared CD41 T cell differentiationet al., 1990) was cultured with spleen cells from B6
and transgenic mice of Ao/oIio/o background or those of in the thymus among these lines. While the proportion
of CD41CD82NK1.11 T cells selected by nonclassicalAo/oIi1/1 background in the presence of various concen-
trations of 50V. Spleen cells from B6 and B2H Ao/oIi1/1 MHC class I molecules such as CD1 was less than 2%
of CD41CD82 T cells in B6 (Bendelac et al., 1994, 1995),stimulated BV2-3-1, although an approximately 27-fold
higher concentration of the peptide was required for a considerable number of CD41CD82NK1.11 T cells
(8%±25% of CD41CD82 T cells, depending on the ana-spleen cells from B2H Ao/oIi1/1 than for B6 spleen cells
to reach the maximal response. However, spleen cells lyzed lines) was found in transgenic mouse lines. To
avoid the contamination of this population, expressionfrom B2H Ao/oIio/o were unable to present the peptide at
any concentration tested (Figure 3A). Similar but less of CD4 and CD8 on the thymocytes that did not express
NK1.1 was analyzed. Immature CD41CD81 T cells differ-robust stimulation was observed with spleen cells from
H3 Ao/oIi1/1, but not from H3 Ao/oIio/o. Spleen cells from entiated into mature CD41CD82 T cells via CD41CD8int
stage in B2L Ao/oIio/o and H3 Ao/oIio/o. Surprisingly, how-B2L Ao/oIi1/1 as well as from B2L Ao/oIio/o did not stimulate
BV2-3-1, probably due to the low I-Ab expression on ever, no definite CD41CD82 T cells were observed in B2H
Ao/oIio/o (Figure 4A). Consistent with the differentiation, thespleen cells in this line (data not shown). In contrast,
spleen cells from B2H Ao/oIio/o, H3 Ao/oIio/o, and B2L Ao/oIio/o expression levels of TCRab on CD41CD82 NK1.12HSA2
T cells in B2L Ao/oIio/o and H3 Ao/oIio/o were slightly higherstimulated a T cell hybridoma, BEa16-3, specific for
I-Ab/Ea52-68 complex in the absence of the exogenous than that in Ao/oIio/o, whereas the expression level in B2H
Ao/oIio/o was comparable to that in Ao/oIio/o (Figure 4B). ItEa52-68 (Figure 3B). Taken together, these observa-
tions provide the stronger evidence that I-Ab molecules is unlikely that the failure of CD41 T cell differentiation
Immunity
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Figure 4. Phenotypic Analysis for CD41 T Cell Differentiation in Transgenic Mouse Lines
(A) Thymocytes were prepared from B6 and transgenic mouse lines of Ao/oIio/o background at the age of 6 weeks, and the expression of CD4
and CD8 on the thymocytes that did not express NK1.1 was analyzed. The percentages of CD41CD82, CD41CD8int, CD41CD81, and CD42CD81
cells are indicated. For each line, at least 4 mice were analyzed. Each value for the percentage of CD41CD82NK1.12 T cells was as follows:
Ao/oIio/o, 0.5, 0.6, 0.6, 0.5; B2H Ao/oIio/o, 0.7, 0.6, 0.6, 0.4, 0.4; H3 Ao/oIio/o, 1.1, 1.4, 1.6, 1.3; B2L Ao/oIio/o, 1.6, 2.2, 2.1, 1.7; and B6, 9.5, 10.0, 9.6,
8.5.
(B) The expression of TCRab on CD41CD82NK1.12HSA2 thymocytes was compared among transgenic mouse lines of Ao/oIio/o background.
The mean channels for the intensity of TCRab are indicated. The results represent two independent experiments.
(C) Thymocytes were prepared from transgenic mice of Ao/oIi1/1 background at 8±10 weeks old and were analyzed as described in (A). For
B2H, two B2H Ao/oIi1/1 and three B2H Ao/oIi1/2 were analyzed. Each value for the percentage of CD41CD82NK1.12 T cells was as follows:
Ao/oIi1/1, 0.7, 0.3, 0.3; B2H Ao/oIi1/1 or B2H Ao/oIi1/2, 2.4, 1.9, 2.2, 1.5, 1.5; H3 Ao/oIio/o, 1.4, 1.6, 1.6; and B2L Ao/oIi1/1, 4.1, 2.9.
(D) The number of CD41CD82NK1.12 T cells per thymus from B6 and transgenic mouse lines of Ao/oIio/o background. At least four mice were
analyzed for each line, and the mean plus one standard deviation is shown.
(E) The ratio of the number of CD41CD82NK1.12 T cells to that of CD41CD82NK1.11 T cells in the thymus from B6 and transgenic mouse
lines of Ao/oIio/o background. At least four mice were analyzed for each line, and the mean plus one standard deviation is shown.
in B2H Ao/oIio/o resulted from some T cell defects causing was observed with H3 Ao/oIio/o and B2H Ao/oIio/o (Figure 5A).
To further characterize CD41 LN T cells, we examineddifferentiation arrest, because a considerable number
of CD41CD82NK1.12 T cells were observed in B2H mixed lymphocyte reaction between B6 and transgenic
mouse lines. CD41 T cells from B2L Ao/oIio/o and H3 Ao/oIio/oAo/oIi1/1, in which some of the Ea52-68 peptides bound
to I-Ab molecules were replaced by other peptides (Figure responded well to B6 spleen cells expressing wild-type
I-Ab molecules, but did not show any response to spleen4C). The number of CD41CD82NK1.12 T cells per thymus
in B2L Ao/oIio/o and H3 Ao/oIio/o was 3.6 times and 1.8 times cells prepared from B2H Ao/oIio/o as well as those from
syngeneic mice (Figure 5B). These observationsare con-higher, respectively, than that in Ao/Iio/o, whereas the
number in B2H Ao/oIio/o was comparable to that in Ao/oIio/o, sistent with the recent reports showing that CD41 T cells
positively selected by a single ligand recognize otherwhich lacks MHC class II expression (Figure 4D). The
ratio of the number of CD41CD82NK1.12 T cells to that peptides bound to the same MHC class II molecules but
are tolerant to the selecting ligand (Fung-Leung et al.,of CD41CD82NK1.11 T cells, which would be a good
indicator to assess the degree of CD41 T cell differentia- 1996; Ignatowicz et al., 1996; Martin et al., 1996; Miya-
zaki et al., 1996). However, neither the LN CD41 T cellstion directed by I-Ab/Ea52-68 complex because a similar
number of CD41CD82NK1.11 T cells was observed in from B2H Ao/oIio/o nor those from Ao/oIio/o showed any
proliferation to B6 spleen cells, indicating a lack of thethese mice analyzed at 6 weeks old, agreed with this
(Figure 4E). LN CD41 T cells differentiated in the context of I-Ab/
Ea52-68 complex in B2H Ao/oIio/o (Figure 5C).
Mixed Lymphocyte Reaction between B6
and Transgenic Mouse Lines TCR Va and Vb Usages of CD41CD82NK1.12HSA2
Thymocytes from Transgenic Mouse LinesThe proportion of CD41 T cells in lymph node (LN) cells
was found to increase remarkably in B2L Ao/oIio/o as com- To assess TCRrepertoire selected by I-Ab/Ea52-68 com-
plex, we analyzed the expression of TCR Vas and Vbspared with that in Ao/oIio/o, whereas no definite increase
Thymic Selection by a Single MHC/Peptide In Vivo
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Figure 5. Phenotypic and Functional Analy-
sis for LN CD41 T Cells in Transgenic Mouse
Lines
(A) The expression of CD4 and CD8 was ana-
lyzed for LN cells that did not express NK1.1.
For each line, two mice were analyzed at the
age of 14±16 weeks.
(B) LN CD41 T cells from B2L Ao/oIio/o (left) or
H3 Ao/oIio/o (right) were cultured with irradiated
spleen cells from syngeneic mouse, B2H
Ao/oIio/o, and B6, and [3H] thymidine incorpora-
tion was measured. The data indicate the
mean plusone standard deviation of triplicate
cultures.
(C) LN CD41 T cells from Ao/oIio/o, B2H Ao/oIio/o,
H3 Ao/oIio/o, and B2L Ao/oIio/o were cultured with
irradiated B6 spleen cells, and [3H] thymidine
incorporation was measured. The data indi-
cate the mean of duplicate cultures.
on CD41CD82NK1.12HSA2 thymocytes from transgenic mouse lines comes from the following three results.
First, preincubation of cells with YAe specific for thismouse lines (Table 1). Compared with the expression in
complex completely inhibited the staining with Y3P,Ao/oIio/o, CD41CD82NK1.12HSA2 T cells from B2L Ao/oIio/o
which recognizes I-Ab molecules irrespective of theand H3 Ao/oIio/o preferentially expressed TCR Va2, Va11,
binding peptides. Second, spleen cells from transgenicVb4, Vb10, Vb12, and Vb14. In contrast, such pref-
mouse lines were unable to present the other I-Ab-bind-erential TCR Va and Vb usages were not observed in
ing peptide, even though a high concentration of theCD41CD82NK1.12HSA2 T cells from B2H Ao/oIio/o, which
peptide was used. Third, LN CD41 T cells from trans-was consistent with the observation that CD41 T cells
genic mouse lines with relatively low expression of I-Ab/were scarcely selected to mature on I-Ab/Ea52-68 com-
Ea52-68 complex showed strong proliferative responseplex in this line.
to B6 spleen cells expressing I-Ab molecules with a nor-
mal array of self-peptides. All of these results are consis-The Frequency of CD41 T Cells Selected to Mature
tent with the recent report by Ignatowicz et al. (1996)on I-Ab/Ea52-68 Complex in B2L Ao/oIio/o Decreases
on a line of transgenic mice expressing the same MHCin the Presence of High Expression
class II/peptide complex as a single species. Therefore,of B2H Transgene
these transgenic mouse lines made it feasible to followTo assess the effect of the expression level of I-Ab/Ea52-
the fate of CD41 T cells directed by the same MHC class68 complex on CD41 T cell differentiation more directly,
II/peptide complex with differential expression levels inCD41 T cells wereanalyzed phenotypicallyand function-
the thymus.ally in Ao/oIio/o expressing both B2L and B2H transgenes
While CD41 T cells were selected to mature on I-Ab/(B2L B2H Ao/oIio/o) obtained by crossing Ao/1Iio/o homozy-
Ea52-68 complex in B2L Ao/oIio/o and H3 Ao/oIio/o with rela-
gous for B2L transgenes with B2H Ao/oIio/o and compared
tively low expression of this complex in the thymus,
with those from B2L Ao/oIio/o littermate. The proportion
CD41 T cells surviving thymic selection by this complex
of CD41CD82NK1.12 T cells in the thymus from B2L
could not be detected in B2H Ao/oIio/o, in which I-Ab/Ea52-
B2H Ao/oIio/o was much lower than that from B2L Ao/oIio/o 68 complexes were expressed in the thymus at a higher
littermate (Figure 6A). Consistent with this, LN CD41 T level than that in B2L Ao/oIio/o and H3 Ao/oIio/o. It is clear
cells from B2L B2H Ao/oIio/o showed a less robust prolifer- that the failure of CD41 T cell differentiation observed
ative response to B6 spleen cells than did those from in B2H Ao/oIio/o results neither from the lack of this com-
B2L Ao/oIio/o (Figure 6B). These observations indicate that plex in thymic cortex nor from some T cell defects caus-
the frequency of CD41 T cells selected to mature on ing differentiation arrest. In addition, the frequency of
I-Ab/Ea52-68 complex in the thymus from B2L B2H CD41 T cells selected to mature on I-Ab/Ea52-68 com-
Ao/oIio/o markedly decreases as compared with that from plex was shown to markedly decrease in B2L B2H
B2L Ao/oIio/o, although a small number of CD41 T cells Ao/oIio/o. Since the only difference among these trans-
survive thymic selection by I-Ab/Ea52-68 complex in this genic mouse lines is the expression level of I-Ab/Ea52-
line. 68 complex, our findings provide in vivo evidence that
the cell surface density of a given MHC class II/peptide
Discussion complex in the thymus plays a crucial role in determining
the fate of CD41 T cells.
In the present study, we have compared the fate of CD41 It was recently reported by several groups that CD41
T cells among transgenic mouse lines expressing I-Ab T cells selected by a single MHC class II/peptide com-
molecules covalently bound to Ea52-68 at different lev- plex are tolerant to this selecting ligand (Fung-Leung et
els in the thymus. The evidence that an I-Ab molecule al., 1996; Ignatowicz et al., 1996; Martin et al., 1996).
covalently bound to Ea52-68 is expressed as a single However, it remains unclear from their experiments
whether the same MHC class II/peptide complex directsMHC class II/peptide complex in these transgenic
Immunity
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Figure 6. Phenotypic and Functional Analysis for CD41 T Cell Differ-
entiation in B2L B2H Ao/oIio/o
(A) Thymocytes from B2L B2H Ao/oIio/o (right) and B2L Ao/oIio/o lit-
termate (left) were prepared, and CD4 and CD8 expression on thy-
mocytes that did not express NK1.1 was analyzed. The data repre-
sent three independent experiments.
(B) LN CD41 T cells from B2L B2H Ao/oIio/o, B2L Ao/oIio/o littermate,
and B2H Ao/oIio/o were cultured with irradiated B6 spleen cells, and
[3H] thymidine incorporation was measured. The data indicate the
mean plus one standard deviation of triplicate cultures.
negative selection to eliminate the reactive CD41 T cells
in the thymus, because such tolerance could be ex-
plained by the possibility that CD41 T cells selected by
a single ligand express low affinity TCRs or antagonistic
TCRs for this ligand. We have shown that the frequency
of CD41 thymocytes selected to mature on I-Ab/Ea52-
68 complex decreases in B2L B2H Ao/oIio/o. These obser-
vations indicate that the high expressing B2H trans-
genes have a dominant-negative effect on intrathymic
differentiation of CD41 T cells in B2L Ao/oIio/o. It is unlikely
that higher expression of I-Ab/Ea52-68 complex in the
thymus of B2L B2H Ao/oIio/o decreases the efficiency of
positive selection itself. Our results thus strongly sug-
gest that I-Ab/Ea52-68 complex, being affected by its
cell surface density in the thymus, can serve as nega-
tively selecting ligand as well as positively selecting
ligand in vivo.
Based on a differential avidity model in thymic selec-
tion, it has been predicted that higher expression of a
particular MHC/peptide complex would simply lower the
thresholds for both positive and negative selection, re-
sulting in the deletion of more T cells, but a new collec-
tion of T cells expressing TCRs with lower affinity for
this complex could be successfully positively selected
(Allen, 1994). Surprisingly, however, this was not the
case with B2H Ao/oIio/o in which CD41 T cells expressing
TCRs with any affinity for I-Ab/Ea52-68 complex could
not survive thymic selection by this complex. Several
lines of evidence have indicated that epithelial cells in
thymic cortex mediate positive selection (Benoist and
Mathis, 1989; Berg et al., 1989; Bill and Palmer, 1989),
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thymic medulla mediate negative selection (Marrack et expression in the thymus generatesnormal level of CD41
al., 1988; Burkly et al., 1993; Laufer et al., 1996). In addi- T cells in Iio/o mice reconstituted with transgenic Ii iso-
tion, the distinct features of these stroma cells, including forms (Naujokas et al., 1995; Shachar et al., 1995). It is
antigen-presenting capacity, associate molecule ex- highly conceivable that CD41 T cells in H3 Ao/oIio/o ex-
pression, and the interaction with thymocytes at differ- press higheraffinity TCRsfor I-Ab/Ea52-68 complex than
ent stages of development, have been reported (Lorenz those in B2L Ao/oIio/o. To examine this, we have compared
and Allen, 1989; Mizuochi et al., 1992; Degermann et al., the proliferative response of LN CD41 T cells to B2H
1994). Thus, it is suggested that the stroma cells in Ao/oIio/o spleen cells in the presence of cytokines or sub-
thymic cortex and medulla are programmed anatomi- optimal concentration of phorbol 12-myristate 13-ace-
cally and genetically to play a different role in thymic tate and ionomycin, or cytokine production by CD41 T
selection. In light of this, the ratio of the expression of cells and interleukin-2 (IL-2) receptor expression on
a given MHC/peptide complex in thymic cortex to that CD41 T cells stimulated by B2H Ao/oIio/o spleen cells be-
in thymic medulla could be a ªreallyº critical parameter tween B2L Ao/oIio/o and H3 Ao/oIio/o (data not shown). Thus
in determining the fate of T cells directed by this ligand in far, however, no evidence has been obtained indicating
vivo. The expression of I-Ab/Ea52-68 complex in thymic that CD41 T cells from H3 Ao/oIio/o are more susceptible
medulla in B2H Ao/oIio/o is 5±10 times higher than that in to activation by I-Ab/Ea52-68 complex than are those
B2L Ao/oIio/o, whereas the difference in the expression from B2L Ao/oIio/o. These results lead us to speculate that
level in thymic cortex between these two lines appears the threshold of the avidity of TCRs for the selecting
to be much less than that in thymic medulla. Therefore, ligand required for negative selection is much lower than
such expression in B2H Ao/oIio/o would lower the thresh- that required to stimulate peripheral T cells. This might
old for negative selection rather than that for positive be important in preventing T cells from inducing autoim-
selection as compared with the threshold in B2L Ao/oIio/o, mune process against the selecting ligand, as was sug-
causing negative selection by I-Ab/Ea52-68 complex to gested by Pircher et al. (1991), especially under condi-
dominate positive selection by this complex. In contrast tions enhancing MHC expression.
to the results on B2H Ao/oIio/o, a small but definite number Several studies in vitro and in vivo, including this
of CD41CD82 T cells was found to be selected to mature study, have shown that T cellsselected by a single MHC/
on I-Ab/Ea52-68 complex in B2L B2H Ao/oIio/o. This sug- peptide complex express polyclonal TCRs (Ashton-
gests that the higher ratio of I-Ab/Ea52-68 complex ex-
Rickardt et al., 1993; Ignatowicz et al., 1996; Miyazaki
pression in thymic cortex to that in thymic medulla in
et al., 1996). Are there any structural features of TCRs
B2L B2H Ao/oIio/o than that in B2H Ao/oIio/o allows CD41 T
selected by a single ligand? We have shown that
cells expressing relatively low affinity TCRs for this li-
CD41CD82NK1.12HSA2 T cells from both B2L Ao/oIio/o
gand to mature in this line.
and H3 Ao/oIio/o express preferentially TCR Va2, Va11,
It has been reported that a reduced but definite num-
Vb4, Vb10, Vb12, and Vb14. This preferential TCR Vaber of CD41CD82 T cells is generated in the thymus of
and Vb usage seems unlikely to result from the seg-H-2M-deficient mice in which I-Ab molecules are almost
regation of self-superantigens, because it was closelyoccupied with a single peptide, Ii-derived CLIP, and are
correlated with the CD41 T cell differentiation directedexpressed on the cell surface, probably at a higher level
by I-Ab/Ea52-68 complex, and four mice analyzed inde-than that in B2H Ao/oIio/o (Fung-Leung et al., 1996; Martin
pendently for each line showed similar values. There-et al., 1996; Miyazaki et al., 1996). The expression of
fore, CD41CD82 T cells selected to mature on I-Ab/Ea52-I-Ab/CLIP complex in thymic cortex appears to be con-
68 complex might express relatively limited TCRs withsiderably higher than that of I-Ab/Ea52-68 complex in
some common structual features. In this point of view,B2H Ao/oIio/o (Fung-Leung et al., 1996). Therefore, similar
it might be interesting to note that TCR Vb4, Vb10, andto the case with B2L B2H Ao/oIio/o, the difference could be
Vb12 bear quite similar amino acid sequences at com-explained by the possibility that CD41 T cells expressing
plementary determining region (CDR) 1 (Arden et al.,TCRs with relatively low affinity for the selecting ligand
1995; for Vb12, our unpublished data). Further experi-are allowed to mature in H-2M-deficient mice. Alterna-
ments would be done in greater detail using thesetively, the majority of CD41CD82 T cells in H-2M-defi-
transgenic mouse lines additionally lacking b2-micro-cient mice might be selected by peptides other than
globulin expression in which CD41CD82 T cells selectedCLIP expressed in association with I-Ab on the cell sur-
by nonclassical and probably classical MHC class I mol-face at a low level in the thymus, because CLIP bound
ecules could be excluded.to I-Ab molecules in H-2M-deficient mice, different from
The exact stage at which negative selection occursthe case with Ea52-68 covalently bound to I-Ab mole-
is somewhat controversial. Some studies using TCRabcules in B2H Ao/oIio/o, has been found to be replaced by
transgenic mice have indicated that negative selectionother exogenous peptides (Martin et al., 1996; Miyazaki
to nominal antigenic peptide occurs at CD41CD81 stageet al., 1996).
(Kisielow et al., 1988a; Sha et al., 1988b; Murphy et al.,It is interesting that a small but definite number of
1990), whereas others using TCRb or non±TCR trans-CD41CD82 T cells was selected to mature on I-Ab/Ea52-
genic mice have suggested that negative selection to68 complex in H3 Ao/oIio/o, in which this complex was
self-superantigens occurs at the transition stage fromscarcely detected in thymic cortex and weakly ex-
CD41CD81 stage to CD41CD82 or CD42CD81 stagepressed in thymic medulla. Taking into consideration
(Berg et al., 1989; Guidos et al., 1990). Such differencethat I-Ab/Ea52-68 complex is the only MHC class II/
might result from the earlier and higher TCRab ex-peptide complex directing thymic selection of CD41 T
pression in TCRab transgenic mice than that in TCRbcells in H3 Ao/oIio/o, these observations support the re-
ports showing that a quite low level of MHC class II and non±TCR transgenic mice or from the difference in
Immunity
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Short-Term Thymic Epithelial Cell Cultureself-antigens analyzed in these studies. In B2H Ao/oIio/o,
Thymi isolated from mice 4±6 weeks old were minced, incubatedCD41 T cell differentiation appears to be arrested at
for 30 min in phosphate-buffered saline (PBS) containing 1 mMCD41CD8int stage. It is possible that high TCRab expres-
EDTA, and cultured in MEM containing D-valin (GIBCO BRL, Grand
sion and CD4 coreceptor engagement at CD41CD8int Island, New York) and 10% FCS, as previously described by Sen-
stage increase the avidity of TCRs for I-Ab/Ea52-68 com- Majumdar et al. (1992). In the3 week course of the culture, nonadher-
ent cells were extensively removed and used for flow cytometricplex and lead to negative selection at this stage in B2H
analysis.Ao/oIio/o. Alternatively, CD41CD8int T cells in this line might
just reflect the population selected by MHC class I mole-
Flow Cytometrycules, as shown by Chan et al. (1993), and negative
The expression of I-Ab/Ea52-68 complex on spleen cells was ana-
selection by I-Ab/Ea52-68 complex might occur at lyzed by staining the cells with FITC-anti-B220 MAb and biotinylated
CD41CD81 stage. The analysis for CD41 T cell differenti- Y3P or biotinylated YAe, followed by streptavidin-PE (Becton-Dick-
ation in B2H Ao/oIio/o lacking b2-microglobulin expression inson, Mountain View, California). To assess the expression of I-Ab/
Ea52-68 complex on thymic epithelial cells, short-term cultured thy-would also aid in distinguishing these possibilities and
mic epithelial cell lines were incubated with IFN-g at 100 U/ml forallow us to assess the stage at which negative selection
48 hr and stained with biotinylated Y3P or control antibody, followedby MHC/peptide complexes occurs under nearly physio-
by streptavidin-PE. All reagents were used at 1 mg/ml. For the pre-
logical conditions. treatment of YAe, cells were incubated with unlabeled YAe at 50
In summary, we have shown that a single MHC class mg/ml before the staining with Y3P. Analysis was done ona FACScan
II/peptide complex, being affected by its expression (Becton-Dickinson).
To assess the differentiation of CD41 T cells directed by I-Ab/level in thymic cortex and medulla, can serve as both
Ea52-68 complex, thymocytes and LN cells were stained with PE-positively and negatively selecting ligand for CD41 T
anti-CD4, FITC-anti-CD8, and biotinylated anti-NK1.1 MAbs, fol-cells in vivo, using transgenic mouse lines expressing
lowed by streptavidin-Cy-Chrome (Pharmingen), and CD4 and CD8
this complex at different levels in the thymus. These expression on thymocytes or LN cells that did not express NK1.1
transgenic mouse lines would be good tools to investi- was analyzed on a FACScan. All reagents were used at 10 mg/ml.
gate the interaction of TCRs with a given MHC/peptide The expression of TCR ab, TCR Vas, and TCR Vbs on CD41CD82
thymocytes was analyzed as follows. Thymocytes were incubatedcomplex in thymic selection and facilitate biochemical
with anti-CD8 and anti-HSA MAbs, followed by rabbit complementanalysis to reveal the molecular mechanism undergoing
to remove immature thymocytes and CD42CD81 thymocytes. Viablepositive and negative selection.
cells were recovered using Lympholyte-M (Cedarlane, Ontario, Can-
ada) and stained with PE-anti-CD4, FITC-anti-TCR ab, FITC-anti-
Experimental Procedures TCR Va or Vb, and biotinylated anti-NK1.1 MAbs, followed by
streptavidin-Cy-Chrome. All reagents were used at 10 mg/ml. By
Construct Used for Making Transgenic Mouse Expressing gating out NK1.11 T cells, expression of TCR ab, Vas, or Vbs on
I-Ab Molecules Covalently Bound to Ea52-68 CD41CD82NK1.12HSA2T cells was analyzed on a FACScan.
The nucleotide sequence corresponding to Ea52-68 and a flexible
linker was introduced into the sequence encoding the third and the Immunohistochemical Analysis
fourth amino acid residues of the I-Abb chain by polymerase chain Frozen thymus sections (4 mm in thickness) were prepared using a
reaction (PCR) using cDNA obtained from B6 spleen. The follow- cryostat and fixed in cold acetone. The sections were first incubated
ing oligonucleotides were used in the PCR: primer A, AGAGCTC with biotinylated YAe, then reacted with peroxidase-avidin, andwere
CCCACTGGCTTTGGCTGGAGACTCCGCTTCTTTCGAAGCTCAAG visualized in a fresh mixture of 0.02% 3-39-diaminobenzidine and
GTGCTTTAGCTAATATTGCTGTCGACGAAAGGCATTTCGTGTAC 0.005% H2O2 in Tris±HCl buffer (0.05 M, pH 7.6).
CAG; primer B, AGTCGACAAGGCTGGTGGTGGTGGTTCTTTAGTT
CCTAGAGGTGGTAGTGAAAGGCATTTCGTGTACCAG; and primer T Cell Hybridoma Stimulation
C, TTAAGCTTGTCAACTGAGTCAAAACACTCT. Briefly, the SalI± The following T cell hybridomas were used: BV2-3-1 specific for
HindIII fragment of the amplified DNA using primers A and C was pigeon cytochrome c±derived analog peptide (50V) restricted by
replaced with the amplified DNA using primers B and C at these I-Ab molecules (a gift from Dr. K. Ogasawara) and BEa16-3 specific
sites incorporated into the primers, and the SacI±HindIII fragment for Ea52-68 restricted by I-Ab molecules (a gift from Dr. P. Marrack).
was subcloned into the PDR 51 vector to express this chimeric gene The stimulation experiment was done by cultivating a T cell hybrid-
under HLA-DRB promoter, which allows tissue-specific expression oma (1 3 105/well) with irradiated spleen cells (30 Gy from a 137Cs
in vivo (Yamamoto et al., 1994). The predicted amino acid sequence source; 5 3 105/well) in the presence or absence of the relevant
introduced between the third and fourth amino residues of the I-Abb peptide. Fifty microliters of the supernatant was recovered from the
chain was ASFEAQGALANIAVDKAGGGGSLVPRGGS. culture after 24 hr, and the amount of IL-2 was quantified by the
proliferative response of the IL-2-dependent cell line, CTLL (5 3
103/well).Antibodies
The following MAbs were purchased from Pharmingen (San Diego,
Mixed Lymphocyte ReactionCalifornia): fluorescein isothiocyanate (FITC)-anti-CD45R (B220,
LN CD41 T cells were prepared by eliminating CD81 T cells and BRA3-6B2); phycoerythrin (PE)-anti-CD4 (RM4-5); FITC-conjugated
cells from LN cells using anti-CD8 antibody, followed by immuno-or purified anti-CD8 (53-6.7); biotinylated anti-NK1.1 (PK136); puri-
magnetic beads coated with anti-Rat IgG antibody and those coatedfied anti-CD24 (HSA, J11D); FITC-anti-TCRab (H57-597); FITC-anti-
with anti-mouse IgG antibody (both from DYNAL, Oslo, Norway). LNTCR Va2 (B20.1); Va3.2 (RR3-16), Va8 (B21.14), and Va11 (RR8-1);
CD41 T cells (1 3 105/well) were cultured with irradiated spleen cellsand FITC-anti-TCR Vb2 (B20.6), Vb4 (KT4), Vb5 (MR9.4), Vb6
(1 3 106/well) for 80 hr, and 1 mCi of [3H] thymidine was added during(RR4-7), Vb7 (TR310), Vb8 (MR5-2), Vb9 (MR10-2), Vb10 (B21.5),
the final 16 hr of the culture.Vb11 (RR3-15), Vb12 (MR11-1), Vb13 (MR12-3), and Vb14 (14-2).
The mouse IgM MAbs specific for CD8 used for the killing experi-
ments were purchased fron Meiji Institute of Health Science (Tokyo, Acknowledgments
Japan). MAbs Y3P (anti-I-Ab; a gift from Dr. M. Kimoto) or YAe (anti-
I-Ab/Ea52-68; a gift from Dr. D. B. Murphy) were isolated from super- We thank Drs. D. Mathis and C. Benoist for mice deficient in wild-
type I-Abb or invariant chain and for helpful discussions; Dr. D. B.natants of hybridoma cell cultures using a protein G column and
were biotinylated with long arm NHS-biotin (Vector Laboratories, Murphy for the B cell hybridoma YAe; Dr. M. Kimoto for the B cell
hybridoma Y3P; Dr. P. Marrack for a T cell hybridoma specific forBurlingame, California).
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I-Ab/Ea52-68 complex; Dr. K. Ogasawara for a T cell hybridoma (1990). T cell receptor±mediated negative selection of autoreactive
T lymphocyte precursors occurs after commitment to the CD4 orspecific for I-Ab/50V complex. We would like to give special thanks
to A. Inayoshi for her excellent technical assistance. This work was CD8 lineages. J. Exp. Med. 172, 835±845.
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from the Ministry of Education, Science, Sports and Culture, Japan. tion of CD81 T cells induced by major histocompatibility complex
binding peptides in fetal thymus organ culture. J. Exp. Med. 177,
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